World Lung Day 2024

September 25th marks this year’s observance and celebration of World Lung Day!

Past event

25September2024

Learning objectives

Understand the consequences of poor lung function in adult and pediatric asthma patients
Recognize the techniques available to monitor lung function and overall lung health
Discover the complex factors that contribute to the progressive nature of COPD

Description

Explore our educational resources about the consequences of inflammation on lung health in severe asthma and COPD.

Related resources

Importance of Lung Function Assessment in Adult Asthma Patients

Pulmonology

3 min

videoanimation

Importance of Lung Function Assessment in Adult Asthma Patients

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management

Pulmonology

5 min

interactivity

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: FinlandChange country/region